Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000414378 | SCV000491502 | likely pathogenic | not provided | 2024-08-26 | criteria provided, single submitter | clinical testing | Observed with a second UNC13D variant in a patient with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (PMID: 33658321); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33658321) |
Labcorp Genetics |
RCV001861424 | SCV002118545 | pathogenic | Familial hemophagocytic lymphohistiocytosis 3 | 2021-04-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with UNC13D-related conditions. ClinVar contains an entry for this variant (Variation ID: 372959). This variant is present in population databases (rs747169857, ExAC 0.003%). This sequence change creates a premature translational stop signal (p.Gln307*) in the UNC13D gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in UNC13D are known to be pathogenic (PMID: 14622600). |
Fulgent Genetics, |
RCV001861424 | SCV002802205 | likely pathogenic | Familial hemophagocytic lymphohistiocytosis 3 | 2022-04-08 | criteria provided, single submitter | clinical testing |